USPTO serial 87892837
CASI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 14, 2019
- Examiner
- SMITH, CYNTHIA RINALDI
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with CASI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stacey J. Watson
Stacey J. Watson MARKERY LAW LLCPO BOX 84150GAITHERSBURG, MD 20883-4150United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Pharmaceutical research and development; development of pharmaceutical preparations and medicines; provision of scientific information via Internet portals in the field of medical research and biotechnology; Product development research and product development in the field of pharmaceutical, biological and biotechnological products; medical research and product development services in the field of treatments for cancer, cardiovascular, metabolic, inflammatory, nervous system, anti-infective, and dermatological conditions; pharmaceutical research and development of human therapeutics using gene editing; Drug discovery services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Biochemical research and development; Biological research; Biomedical research services; Clinical research in the field of cancer; Conducting clinical trials for others in the field of cancer; Conducting early evaluations in the field of new pharmaceuticals; Genotyping services for research or analysis purposes; Laboratory research services relating to pharmaceuticals; Medical research; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical research services; Product research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research; Scientific research and development; Stem cell research; Technical research in the field of pharmaceutical studies | ACTIVE | Jun 16, 2014 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 31, 2025 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Mar 31, 2025 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Mar 31, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 12, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| May 14, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 14, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 26, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 26, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 6, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 16, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 16, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 16, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 16, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 16, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 16, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 16, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 16, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| May 9, 2018 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| May 6, 2018 | ALIE | ASSIGNED TO LIE | — |
| May 4, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 1, 2018 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Apr 28, 2018 | NWAP | NEW APPLICATION ENTERED | — |